Original Article
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2019;
2:
21
(20 December 2019)
Editorial
Bridging clinical medicine with innovative scientific research
Annals of Pancreatic Cancer
2019;
2:
20
(04 December 2019)